[Pargyline and р-Chlorophenylalanine Decrease Expression of Ptpn5 Encoding Striatal-Enriched Protein Tyrosine...

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Striatal-enriched protein tyrosine phosphatase (STEP) is crucial for neuroplasticity, with abnormalities linked to neurodegenerative disorders.
• The STEP inhibitor TC-2153 impacts the brain's serotonergic system, but the reverse influence remains unstudied.

Purpose of the Study:

• To investigate how pharmacologically altered brain serotonin (5-HT) levels affect Ptpn5 gene expression and STEP activity in mice.

Main Methods:

• Mice received 5-HT synthesis inhibitor (p-chlorophenylalanine) or degradation inhibitor (pargyline) for three days.
• Serotonin levels were measured using HPLC; STEP activity was assayed spectrophotometrically.
• Ptpn5 mRNA levels were quantified using RT-PCR.

Main Results:

• Ptpn5 mRNA expression was significantly higher in the striatum compared to the cortex and hippocampus.
• Both increased and decreased brain 5-HT levels led to a decrease in striatal Ptpn5 mRNA.
• Neither p-chlorophenylalanine nor pargyline affected STEP activity in the tested brain regions.

Conclusions:

• Pharmacological modulation of brain 5-HT levels decreases Ptpn5 mRNA expression in the mouse striatum.
• A novel method for studying STEP activity in the brain was proposed.
• The serotonergic system influences Ptpn5 expression, but not directly STEP activity.